For press inquiries click here to contact us.
Smart Biotech Scientist Podcast with David Bruhlmann
Why Strong Science Isn’t Enough to Get Funded: What Investors Actually Look For
PharmaVoice
China’s biopharma advance draws financial investment
Genetic Engineering & Biotechnology News
On Its 15th Anniversary, Foresite Capital Looks Ahead
Venture with Grace
Jim Tananbaum, Foresite Capital Founder on Healthcare & Life Sciences
Biotech2050
Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to uncover the patterns behind biotech innovation and venture success.
The Full Ratchet
From Data Science to Drug Design: How AI Shifts Discovery, Target Validation, and Portfolio Construction (Jim Tananbaum)
Press Release
Hyung Chun and Cindy Xiong Promoted to Partner at Foresite Capital
Press Release
Foresite Capital Raises $900M to Invest in Healthcare and Life Science Startups at All Stages
Press Release
Foresite Capital Strengthens Investor Relations and Business Development Teams with Addition of Hadi Tabbaa as Managing Director
Recognitions by unaffiliated third parties should not be construed as a current or past endorsement of Foresite Capital Management, LLC (“Foresite Capital”) or the private funds it manages. The rankings and recognitions published by Forbes are based on information prepared and submitted by Foresite Capital. Third party ratings are not representative of an individual investor’s investment results or the results of Foresite Capital and its funds. Past performance is no guarantee of future results. Please contact Foresite Capital for more detail on the criteria upon which the Forbes Midas List is based.